Welcome to the E-newsletter of the Nebraska Coalition for Lifesaving Cures December 2016! Below are a few articles that caught our eye this month. Enjoy.
A History of Forward
We formed in 2000 to advance research – stem cell research – and uncover lifesaving cures. This is still what fuels us today. Learn more about our history in our timeline.
Read more here.
Spring Luncheon to Honor Mary Ann “Andy” Holland
Save the Date for NCLC’s Spring Luncheon that will honor Mary Ann “Andy” Holland. The luncheon will take place Monday, April 24, 2017 from 11:30 a.m. – 1 p.m. at the Happy Hollow Club.
Read more here.
Trump win could boost movement to confer ‘personhood’ on fertilized eggs
The push to confer full “personhood” status on every fertilized human egg has been rejected by voters and lawmakers in state after state, including deep-red Mississippi.
But activists are cautiously hopeful that their cause could get a boost from Republicans who are about to assume leadership in Washington.
Read more here.
21st Century’s Cure Act’s passage also suggests a cure for gridlock
Congratulations are due to Congresswoman Diana DeGette and a bipartisan team of lawmakers who managed what seems increasingly difficult in these days of hyper-partisanship and Washington gridlock:
passage of a major bill full of promise for the American people.
President Barack Obama is expected to sign the 21st Century Cures Act, which received massive support in both the House and Senate in recent days, after
years of work on the part of DeGette, the Denver Democrat, and Republican Congressman Fred Upton of Michigan.
Read more here.
The Alliance for Regenerative Medicine Commends Passage of 21st Century Cures Act, Inclusion of Regenerative Medicine-Specific Provisions
The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cellular therapies and broader regenerative medicine sector, commends the U.S. House of Representatives’ bipartisan passage of the 21st Century Cures Act.
ARM is particularly pleased the bill includes regenerative medicine-specific provisions intended to optimize the U.S. Food and Drug Administration’s (FDA) approval pathways for regenerative medicine products, without reducing the agency’s high approval standards for product safety and efficacy.
Read more here.
Asterias interview: stem cell spinal cord injury trials advance
Recently I had the opportunity to talk with the leadership of
Asterias, a California biotech doing exciting clinical research using stem cells as the basis for treatment of spinal cord injury. The interview covers the past (Geron patients), present, and future. I spoke with Asterias President and CEO Stephen Cartt and CMO Edward Wirth.
Read more here.
Upcoming Events
January 10: Science Cafe
Matthew Brown, advanced sommelier and manager of V. Mertz restaurant, will discuss the science of wine at the next Science Cafe, January 10 at 7 p.m. at the Slowdown.
April 24, 2017: Spring Luncheon
Save the Date for NCLC’s Spring Luncheon honoring Mary “Andy” Holland. This event will take place Monday, April 24, 2017 from 11:30 a.m. – 1 p.m. at the Happy Hollow Club.
